Ataxia telangiectasia and acute lymphoblastic leukemia: report of a case.
We report a new case of ataxia-telangiectasia (AT) and acute lymphoblastic leukemia (ALL) and review all 21 known cases of AT and ALL. Leukemia in these patients is associated with a male predominance, age older than 10 years at diagnosis, a white blood cell count higher than 50,000 mm3, and a fatal course. Four patients have been reported who developed T-cell leukemia, 3 null-cell leukemia and 1 B-cell leukemia. The AT-ALL patients appear to be at risk for infections related to their immunodeficient status and ALL chemotherapy. In addition, neurologic deterioration has been noted during the early phase of therapy.
D000367:Age Factors; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001260:Ataxia Telangiectasia / Q000150:complications* / Q000235:genetics; D002648:Child; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D007958:Leukocyte Count; D008214:Lymphocytes; D012737:Sex Factors
D000970:Antineoplastic Agents